Nurses’ perspectives of recognising and responding to unsafe practice by their peers: A national cross-sectional survey

- Blair, Wendy, Kable, Ashley, Palazzi, Kerrin, Courtney-Pratt, Helen, Doran, Evan, Oldmeadow, Christopher

Nurses' recognition and response to unsafe practice by their peers: A qualitative descriptive analysis

- Blair, Wendy, Courtney-Pratt, Helen, Doran, Evan, Kable, Ashley

Mixed method integrative review exploring nurses' recognition and response to unsafe practice

- Blair, Wendy, Kable, Ashley, Courtney-Pratt, Helen, Doran, Evan

Australian pharmaceutical policy and the idea of innovation.

- Doran, Evan, Henry, David, Faunce, Thomas A., Searles, Andrew

Drug promotion in Australia: policy contestation and the tightening of regulation

- Doran, Evan, Löfgren, Hans

Potency, hubris, and susceptibility: the disease mongering critique of pharmaceutical marketing

- Doran, Evan, Hogue, Clare

Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability

- Doran, Evan, Robertson, Jane, Salkeld, Glenn

Moral hazard and prescription medicine use in Australia: the patient perspective

- Doran, Evan, Robertson, Jane, Henry, David

Australia's pharmaceutical cost sharing policy: reducing waste or affordability ?

- Doran, Evan, Robertson, Jane

Part of the fabric and mostly right: an ethnography of ethics in clinical practice

- Doran, Evan, Fleming, Jennifer, Jordens, Christopher, Stewart, Cameron L., Letts, Julie, Kerridge, Ian H.

Moral hazard and prescription medicine use in Australia - the patient perspective

- Doran, Evan, Robertson, Jane, Henry, David

Australian pharmaceutical policy: price control, equity, and drug innovation in Australia

- Doran, Evan, Henry, David, Fauce, Thomas A., Searles, Andrew

Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry

- Henry, David, Doran, Evan, Kerridge, Ian, Hill, Suzanne, McNeill, Paul M., Day, Richard

Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience

- Henry, David Alexander, Kerridge, I. H., Hill, Suzanne, McNeill, P. M., Doran, Evan, Newby, David A., Henderson, Kim M., Maguire, Jane, Stokes, Barrie J., Macdonald, G. J., Day, R. O.

A prompt to the web: the media and health information seeking behaviour

- Hogue, Marie-Clare B., Doran, Evan, Henry, David A.

Disease mongering is now part of the global health debate

- Moynihan, Ray, Doran, Evan, Henry, David

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?

- Parkinson, Lynne, Dolja-Gore, Xenia, Gibson, Richard, Doran, Evan, Notley, Lisa, Stewart Williams, Jenny, Kowal, Paul, Byles, Julie E.

Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy

- Robertson, Jane, Doran, Evan, Henry, David A., Salkeld, Glenn

Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme

- Searles, Andrew, Jefferys, Susannah, Doran, Evan, Henry, David A.

The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?.

- Searles, Andrew, Doran, Evan, Faunce, Thomas A., Henry, David